Retatrutide is the next step after those developed by Eli Lilly, the same company behind Zepbound
Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis
Regular weigh-ins, food logs, and activity notes help individuals understand which habits support progress and which ones hinder it
Circulation 102:915920 Ramlawi B, Feng J, Mieno S, Szabo C, Zsengeller Z, Clements R, Sodha N, Boodhwani M, Bianchi C, Sellke FW (2006) Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Conditions under active investigation include prediabetes, heart failure with preserved ejection fraction, obstructive sleep apnoea, knee osteoarthritis, polycystic ovarian syndrome, and inflammatory bowel disease